🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-521295-60-00
Completed Phase I

Multiple Ascending Dose Study of LY4256984 in Participants with Sporadic Amyotrophic Lateral Sclerosis

2025-521295-60-00 · tracked via the Priya Life Science EU tracker
Sponsor
Eli Lilly & Co.
Sponsor type
Pharmaceutical company
Therapeutic area
Nervous System Diseases
Decision date
02/09/2025
Enrollment target
30
Sites
Belgium, Spain, Netherlands, Germany

Condition studied

Sporadic Amyotrophic Lateral Sclerosis

Eligibility

Age group
65+ years, 18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-521295-60-00 on CTIS ↗ ← All trials in the EU